Natera, Inc. (NTRA)
NASDAQ: NTRA · IEX Real-Time Price · USD
105.98
+4.83 (4.78%)
At close: Jul 19, 2024, 4:00 PM
105.75
-0.23 (-0.22%)
Pre-market: Jul 22, 2024, 7:10 AM EDT

Natera Revenue

Natera had revenue of $1.21B in the twelve months ending March 31, 2024, with 39.26% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $367.74M with 52.11% year-over-year growth. In the year 2023, Natera had annual revenue of $1.08B with 31.99% growth.

Revenue (ttm)
$1.21B
Revenue Growth
+39.26%
P/S Ratio
10.77
Revenue / Employee
$367,008
Employees
3,293
Market Cap
13.01B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.08B262.35M31.99%
Dec 31, 2022820.22M194.74M31.13%
Dec 31, 2021625.49M234.48M59.97%
Dec 31, 2020391.01M88.68M29.33%
Dec 31, 2019302.33M44.67M17.34%
Dec 31, 2018257.65M48.03M22.91%
Dec 31, 2017209.63M-2.89M-1.36%
Dec 31, 2016212.51M22.16M11.64%
Dec 31, 2015190.36M31.07M19.50%
Dec 31, 2014159.29M104.12M188.72%
Dec 31, 201355.17M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Tenet Healthcare 20.91B
DaVita 12.34B
Smith & Nephew 5.55B
Dr. Reddy's Laboratories 3.35B
Revvity 2.73B
Royalty Pharma 2.24B
Medpace Holdings 1.96B
Insulet 1.78B
Revenue Rankings